Back to AMGN Stock Lookup

AMGN – Analyst Ratings

Apr 23, 2014 07:43 AM Amgen (AMGN) Q1 'Disappointing' - Nomura
Mar 28, 2014 09:22 AM Cytokinetics (CYTK) Starts COSMIC-HF Phase II Enrollment; BENEFIT-ALS Still in Focus - Roth
Mar 28, 2014 06:51 AM Amgen (AMGN) Price Target Raised at Jefferies Following Cardiologists Survey
Mar 26, 2014 05:14 PM Morgan Stanley Starts Amgen (AMGN) at Overweight
Mar 17, 2014 11:53 AM Deutsche Bank Comments on Aegerion Pharma (AEGR ) and HOFH PCSK9 Data
Mar 5, 2014 07:50 AM Roth Restarts Cytokinetics (CYTK) at Buy; Get in Now Ahead of April '14 ALS Data
Jan 29, 2014 01:41 PM Amgen (AMGN) Price Target Lifted $138 at Jefferies
Jan 8, 2014 08:00 AM Nomura Securities Starts Amgen (AMGN) at Neutral, $131 PT
Dec 12, 2013 11:14 AM Apple (AAPL), IBM (IBM), CBS (CBS) Among Top 24 Stocks for 2014 - Deutsche Bank
Nov 26, 2013 04:35 PM Piper Jaffray Resumes Amgen (AMGN) at Overweight
Nov 18, 2013 10:24 AM Goldman Maintained CL-Buy on Amgen (AMGN) as Balugrastim Threat Fades
Nov 7, 2013 02:09 PM Goldman Sachs Comments on Amgen's (AMGN) Kyprolis AHS Abstract Data
Oct 22, 2013 11:48 AM Deutsche Bank Reiterates Buy on Amgen (AMGN)
Oct 22, 2013 10:18 AM Aegis Keeps Buy on Medivation (MDVN) Following PREVAIL Analysis; Company Ripe for Takeover (JNJ)
Oct 2, 2013 10:27 AM Amgen's (AMGN) Trebananib ESMO Safety Data 'Good' - Leerink Swann
Sep 3, 2013 01:38 PM Goldman Sachs Reiterates CL-Buy on Amgen (AMGN)
Sep 3, 2013 08:21 AM Cytokinetics (CYTK) / Amgen (AMGN) Omecamtiv Data In-line With Expectations - Leerink Swann
Aug 29, 2013 01:15 PM Amgen (AMGN) PT Lifted to $124 at UBS on Model Update Post Onyx
Aug 26, 2013 01:50 PM Amgen (AMGN) Price Target Raised to $138 at Deutsche Bank
Aug 26, 2013 07:54 AM Amgen (AMGN) Deal for Onyx a Positive on Oncology Expansion & EPS Accretion - Jefferies
Aug 26, 2013 07:47 AM Amgen's (AMGN) / Onyx (ONXX) Deal Viewed as Strategic Positive
Aug 26, 2013 06:42 AM Piper Jaffray Upgrades Amgen (AMGN) to Overweight
Aug 20, 2013 09:59 AM UPDATE: Amgen (AMGN) Seriously Intersted in Onyx (ONXX); Maxim Upgrades Onyx to Buy
Aug 19, 2013 04:52 PM Onyx (ONXX) $130 Takeout Would Not Reflect Oprozomib Potential; Brean Reiterates Buy
Aug 19, 2013 03:09 PM Amgen (AMGN), Onyx (ONXX) Deal Will Go Through Pending New Kyprolis Data
Aug 16, 2013 08:04 AM Low Expectations for AMG 423 Phase 2 Keep Goldman at Buy on Amgen (AMGN)
Aug 15, 2013 11:09 AM Onyx (ONXX) / Amgen (AMGN) Deal Probably Will Happen, Says Deutsche Bank
Aug 9, 2013 11:53 AM Canaccord Keeps Onyx Pharma (ONXX) at Buy; Kyprolis Key, But M&A Next Catalyst
Jul 17, 2013 11:05 AM UPDATE: Leerink Swann Starts Cytokinetics (CYTK) at Outperform
Jul 1, 2013 02:41 PM Brean Capital Boosts Onyx Pharma (ONXX) Price Target to $160
Jul 1, 2013 09:34 AM Leerink Swann Raies Onyx (ONXX) Price Target to $140
Jun 28, 2013 01:09 PM Goldman Sachs Comments on Biosimilar Remicade Approval in EU (HSP) (ACT) (TEVA) (NVS) (ABBV)
Jun 13, 2013 07:34 AM Needham & Company Sees 150% Upside in Cytokinetics (CYTK) after Expanded Amgen (AMGN) Deal
Jun 12, 2013 12:49 PM Deutsche Bank Maintains Buy on Amgen (AMGN)
Jun 3, 2013 07:39 AM Amgen (AMGN) T-VEC Data Highlighted at ASCO - Jefferies
May 1, 2013 07:20 AM Goldman Sachs Downgrades Biogen (BIIB) to Neutral, Removes from CL List
May 1, 2013 06:45 AM Goldman Sachs Upgrades Amgen (AMGN) to Conviction Buy
Apr 24, 2013 12:24 PM Amgen (AMGN) EPS Growth is 'Healthy', Target Raised - Jefferies
Apr 24, 2013 06:40 AM Piper Jaffray Downgrades Amgen (AMGN) to Neutral
Feb 19, 2013 01:02 PM Sell and Sell Aggressively, Says Carter Worth
Feb 11, 2013 08:50 AM William Blair Downgrades Amgen (AMGN) to Market Perform
Jan 25, 2013 08:14 AM Argus Upgrades Amgen (AMGN) to Buy
Jan 22, 2013 08:24 AM Credit Suisse Downgrades Amgen (AMGN) to Neutral
Dec 13, 2012 09:08 AM Goldman Sachs Resumes Amgen (AMGN) at Neutral
Nov 26, 2012 11:37 AM Oppenheimer Sees 30-35% Dividend Hike at Amgen (AMGN)
Nov 9, 2012 09:46 AM Guggenheim Starts Amgen (AMGN) at Neutral
Nov 7, 2012 10:09 AM RBC Thinks Amgen's (AMGN) AMG145 Has 'Compelling' Safety Profile Profile; Sees $10B Market Opportunity
Oct 22, 2012 10:10 AM Deutsche Bank Upgrades Amgen (AMGN) to Buy, EPS Growth and Pipeline Offers Upside
Sep 27, 2012 07:50 AM Brean Murray Carret & Co. Starts Amgen (AMGN) at Buy, Still Biotech King
Sep 14, 2012 03:53 PM Amgen (AMGN) Could Feel Sting as Xgeva Competitor Takes Away Sales - Analyst

Back to AMGN Stock Lookup